Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries

Cardiovascular Diabetology

Volumn 8, Issue , 2009, Pages

  Gurney, Alison M ^a   Howarth, Frank C ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

CARBACHOL; GLUCOSE; GLYCERYL TRINITRATE; PHENYLEPHRINE; PROSTAGLANDIN F2 ALPHA; SEROTONIN; STREPTOZOCIN; POTASSIUM; VASOCONSTRICTOR AGENT; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY RESISTANCE; ARTICLE; CONTROLLED STUDY; DEPOLARIZATION; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; LUNG ARTERY; MALE; MUSCLE ISOMETRIC CONTRACTION; NONHUMAN; PULMONARY HYPERTENSION; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION; TREATMENT RESPONSE; VASOCONSTRICTION; VASODILATATION; WISTAR RAT; ANIMAL; CALCIUM SIGNALING; CELL MEMBRANE POTENTIAL; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; LUNG CIRCULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY ARTERY; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASCULAR SMOOTH MUSCLE;

ANIMALS; CALCIUM SIGNALING; CARBACHOL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DINOPROST; ENDOTHELIUM, VASCULAR; HYPERTENSION, PULMONARY; MALE; MEMBRANE POTENTIALS; MUSCLE, SMOOTH, VASCULAR; NITROGLYCERIN; PHENYLEPHRINE; POTASSIUM; PULMONARY ARTERY; PULMONARY CIRCULATION; RATS; RATS, WISTAR; SEROTONIN; STREPTOZOCIN; VASCULAR RESISTANCE; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 61349136949     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-8-4     Document Type: Article

References (39)

1. Movahed MR Hashemzadeh M Jamal MM The prevalence of pulmonary embolism and pulmonary hypertension in patients with type II diabetes mellitus Chest 2005, 128:3568-3571 10.1378/chest.128.5.3568 16304314
2. Makarevich AE Valevich VE Pochtavtsev AU Evaluation of pulmonary hypertension in COPD patients with diabetes Adv Med Sci 2007, 52:265-272 18217431
3. Van Marter LJ Leviton A Allred EN Pagano M Sullivan KF Cohen A Epstein MF Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy Pediatrics 1996, 97:658-663 8628603
4. Brands MW Fitzgerald SM Arterial pressure control at the onset of type I diabetes: The role of nitric oxide and the renin-angiotensin system Am J Hypertens 2001, 14(Suppl 1):126-131 10.1016/S0895-7061(01)02079-9
5. Johnstone MT Creager SJ Scales KM Cusco JA Lee BK Creager MA Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus Circulation 1993, 88:2510-2516 8080489
6. Pieper GM Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration Diabetologia 1999, 42:204-213 10.1007/ s001250051140 10064101
7. Okon EB Szado T Laher I McManus B van Breemen C Augmented contractile response of vascular smooth muscle in a diabetic mouse model J Vasc Res 2003, 40:520-530 10.1159/000075238 14646372
8. Bell RH Jr Hye RJ Animal models of diabetes mellitus: Physiology and pathology J Surg Res 1983, 35:433-460 10.1016/0022-4804(83)90034-3 6314046
9. Reinilä A Long-term effects of untreated diabetes on the arterial wall in rat. An ultrastructural study Diabetologia 1981, 20:205-212 10.1007/BF00252629 7014322
10. Reinilä A Koivisto VA Akerblom HK Lipids in the pulmonary artery and the lungs of severely diabetic rats. A histochemical and chemical study Diabetologia 1977, 13:305-310 10.1007/BF01223270 913923
11. Russ RD Tobin BW Differential pulmonary vascular effects of streptozotocin diabetes in male and female rats Proc Soc Exp Biol Med 1998, 217:74-80 9421209
12. Lopez-Lopez JG Moral-Sanz J Frazziano G Gomez-Villalobos MJ Flores-Hernandez J Monjaraz E Cogolludo A Perez-Vizcaino F Diabetes induces pulmonary artery endothelial dysfunction by NADPH oxidase induction Am J Physiol 2008, 295:L727-L732 10.1152/ajpcell.16.2008
13. Rerup CC Drugs producing diabetes through damage of the insulin secreting cells Pharmacol Rev 1970, 22:485-518 4921840
14. Clarkson P Celermajer DS Donald AE Sampson M Sorensen KE Adams M Yue DK Betteridge DJ Deanfield JE Impaired vascular reactivity in insulin-dependent diabetes mellitus is related to disease duration and low density lipoprotein cholesterol levels J Am Coll Cardiol 1996, 28:573-579 10.1016/0735-1097(96)82380-1 8772741
15. Taylor PD Wickenden AD Mirrlees DJ Poston L Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: Effect of treatment with the aldose reductase inhibitor, ponalrestat Br J Pharmacol 1994, 111:42-48 1910054 8012723
16. Junod A Lambert AE Stauffacher W Renold AE Diabetogenic Action of Streptozotocin: Relationship of Dose to Metabolic Response J Clin Invest 1969, 48:2129-2139 297467 4241908 10.1172/JCI106180
17. Casteels R Kitamura K Kuriyama H Suzuki H Excitation-contraction coupling in the smooth muscle cells of the rabbit main pulmonary artery J Physiol 1977, 271:63-79 1353607 915834
18. Leach RM Twort CH Cameron IR Ward JP A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat Clin Sci 1992, 82:55-62 1310918
19. Bian K Doursout MF Murad F Vascular system: Role of nitric oxide in cardiovascular diseases J Clin Hypertens 2008, 10:304-310 10.1111/ j.1751-7176.2008.06632.x
20. Russ RD Tobin BW Pancreatic islet transplantation, but not intensive insulin therapy, corrects the pulmonary vascular complications of streptozotocin diabetes Can J Physiol Pharmacol 1998, 76:407-417 10.1139/ cjpp-76-4-407 9795750
21. Wascher TC Graier WF Bahadori B Toplak H Time course of endothelial dysfunction in diabetes mellitus Circulation 1994, 90:1109-1110 8044928
22. Suzuki H Twarog BM Membrane properties of smooth muscle cells in pulmonary arteries of the rat Am J Physiol 1982, 242:H900-H906 7081460
23. MacLean MR Sweeney G Baird M McCulloch KM Houslay M Morecroft I 5-Hydroxytryptamine receptors mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats Br J Pharmacol 1996, 119:917-930 1915945 8922741
24. Cameron NE Cotter MA Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats: Role of polyol pathway Diabetologia 1992, 35:1011-1019 10.1007/BF02221675 1473611
25. Chang KS Stevens WC Endothelium-dependent increase in vascular sensitivity to phenylephrine in long-term streptozotocin diabetic rat aorta Br J Pharmacol 1992, 107:983-990 1907920 1467844
26. MacLean MR Pulmonary hypertension, anorexigens and 5-HT: Pharmacological synergism in action? Trends Pharmacol Sci 1999, 20:490-495 10.1016/ S0165-6147(99)01389-9 10603491
27. Dempsie Y Maclean MR Pulmonary hypertension: Therapeutic targets within the serotonin system Br J Pharmacol 2008, 155:455-462 10.1038/ bjp.2008.241 18536742
28. Barradas MA Gill DS Fonseca VA Mikhailidis DP Dandona P Intraplatelet serotonin in patients with diabetes mellitus and peripheral vascular disease Eur J Clin Invest 1988, 18:399-404 10.1111/ j.1365-2362.1988.tb01030.x 3139426
29. Martín FJ Míguez JM Aldegunde M Atienza G Platelet serotonin transport is altered in streptozotocin-induced diabetic rats Life Sci 1995, 56:1807-1815 10.1016/0024-3205(95)00152-V 7739355
30. Petrisiæ MS Augood SJ Bicknell RJ Monoamine transporter gene expression in the central nervous system in diabetes mellitus J Neurochem 1997, 68:2435-2441 9166737
31. MacLean MR Deuchar GA Hicks MN Morecroft I Shen S Sheward J Colston J Loughlin L Nilsen M Dempsie Y Harmar A Overexpression of the 5-hydroxytryptamine transporter gene: Effect on pulmonary hemodynamics and hypoxia-induced pulmonary hypertension Circulation 2004, 109:2150-2155 10.1161/01.CIR.0000127375.56172.92 15078799
32. Wakabayashi I Hatake K Kimura N Kakishita E Nagai K Modulation of vascular tonus by the endothelium in experimental diabetes Life Sci 1987, 40:643-648 10.1016/0024-3205(87)90265-7 3807653
33. Oyama Y Kawasaki H Hattori Y Kanno M Attenuation of endothelium-dependent relaxation in aorta from diabetic rats Eur J Pharmacol 1986, 132:75-78 10.1016/0014-2999(86)90013-0 3816968
34. Kamata K Miyata N Kasuya Y Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats Br J Pharmacol 1989, 97:614-618 1854523 2547480
35. Otter DJ Chess-Williams R The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetic rats Br J Pharmacol 1994, 113:576-580 1510137 7834210
36. Utkan T Sarioglu Y Yildirim S Impaired contraction and relaxation in the aorta of streptozotocin-diabetic rats Pharmacology 1998, 56:207-215 10.1159/000028199 9566022
37. Bhardwaj R Moore PK Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats J Pharm Pharmacol 1988, 40:739-742 2907547
38. Taylor PD McCarthy AL Thomas CR Poston L Endothelium-dependent relaxation and noradrenaline sensitivity in mesenteric resistance arteries of streptozotocin-induced diabetic rats Br J Pharmacol 1992, 107:393-399 1907852 1422588
39. Tawfik HE El-Remessy AB Matragoon S Ma G Caldwell RB Caldwell RW Simvastatin improves diabetes-induced coronary endothelial dysfunction J Pharmacol Exp Ther 2006, 319:386-95 10.1124/jpet.106.106823 16849625